168 related articles for article (PubMed ID: 27257808)
21. Cost-effectiveness analysis of diagnostic-therapeutic strategies for visceral leishmaniasis in Brazil.
Assis TSM; Rabello A; Cota G; Werneck GL; Azeredo-da-Silva ALF
Rev Soc Bras Med Trop; 2019 Apr; 52():e20180272. PubMed ID: 30994802
[TBL] [Abstract][Full Text] [Related]
22. Clinical and Epidemiologic Features of Visceral Leishmaniasis in Children in Southwestern China: A Retrospective Analysis From 2001 to 2015.
Miao R; Wang Z; Guo Q; Wen Y; Liao Q; Zhu Y; Shu M; Wan C
Pediatr Infect Dis J; 2017 Jan; 36(1):9-12. PubMed ID: 27749663
[TBL] [Abstract][Full Text] [Related]
23. The economic impact of visceral leishmaniasis on households in Bangladesh.
Anoopa Sharma D; Bern C; Varghese B; Chowdhury R; Haque R; Ali M; Amann J; Ahluwalia IB; Wagatsuma Y; Breiman RF; Maguire JH; McFarland DA
Trop Med Int Health; 2006 May; 11(5):757-64. PubMed ID: 16640630
[TBL] [Abstract][Full Text] [Related]
24. Effect of meglumine antimoniate on the pancreas during treatment of visceral leishmaniasis in children.
Shahian M; Alborzi A
Med Sci Monit; 2009 Jun; 15(6):CR290-3. PubMed ID: 19478699
[TBL] [Abstract][Full Text] [Related]
25. Serological monitoring of paediatric visceral leishmaniasis By IFA and ELISA methods.
Şakru N; Töz SÖ; Korkmaz M; Özbel Y
Turkiye Parazitol Derg; 2011; 35(3):125-8. PubMed ID: 22203498
[TBL] [Abstract][Full Text] [Related]
26. Treatment of visceral leishmaniasis in children in the Central-West Region of Brazil.
Brustoloni YM; Cunha RV; Cônsolo LZ; Oliveira AL; Dorval ME; Oshiro ET
Infection; 2010 Aug; 38(4):261-7. PubMed ID: 20508967
[TBL] [Abstract][Full Text] [Related]
27. [Treatment of visceral leishmaniasis in children].
Minodier P; Noël G; Blanc P; Uters M; Retornaz K; Garnier JM
Med Trop (Mars); 2007 Feb; 67(1):73-8. PubMed ID: 17506279
[TBL] [Abstract][Full Text] [Related]
28. Visceral leishmaniasis in 13 pediatric patients in Turkey: treatment experience.
Arik Yilmaz E; Tanir G; Tuygun N; Taylan Ozkan A
Turkiye Parazitol Derg; 2009; 33(4):259-62. PubMed ID: 20101572
[TBL] [Abstract][Full Text] [Related]
29. Amphotericin B lipid complex versus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV: a randomized pilot study.
Laguna F; Videla S; Jiménez-Mejías ME; Sirera G; Torre-Cisneros J; Ribera E; Prados D; Clotet B; Sust M; López-Vélez R; Alvar J;
J Antimicrob Chemother; 2003 Sep; 52(3):464-8. PubMed ID: 12888588
[TBL] [Abstract][Full Text] [Related]
30. [Visceral childhood leishmaniasis: diagnosis and treatment].
Prieto Tato LM; La Orden Izquierdo E; Guillén Martín S; Salcedo Lobato E; García Esteban C; García-Bermejo I; Ramos Amador JT
An Pediatr (Barc); 2010 May; 72(5):347-51. PubMed ID: 20378427
[TBL] [Abstract][Full Text] [Related]
31. Pediatric visceral leishmaniasis in Albania: a retrospective analysis of 1,210 consecutive hospitalized patients (1995-2009).
Petrela R; Kuneshka L; Foto E; Zavalani F; Gradoni L
PLoS Negl Trop Dis; 2010 Sep; 4(9):. PubMed ID: 20838650
[TBL] [Abstract][Full Text] [Related]
32. Barriers to treatment for visceral leishmaniasis in hyperendemic areas: India, Bangladesh, Nepal, Brazil and Sudan.
Thornton SJ; Wasan KM; Piecuch A; Lynd LL; Wasan EK
Drug Dev Ind Pharm; 2010 Nov; 36(11):1312-9. PubMed ID: 20545513
[TBL] [Abstract][Full Text] [Related]
33. Mediterranean visceral leishmaniasis in pregnancy.
Gradoni L; Gaeta GB; Pellizzer G; Maisto A; Scalone A
Scand J Infect Dis; 1994; 26(5):627-9. PubMed ID: 7855563
[TBL] [Abstract][Full Text] [Related]
34. Treatment for human visceral leishmaniasis: a cost-effectiveness analysis for Brazil.
de Carvalho IPSF; Peixoto HM; Romero GAS; de Oliveira MRF
Trop Med Int Health; 2019 Sep; 24(9):1064-1077. PubMed ID: 31278808
[TBL] [Abstract][Full Text] [Related]
35. Leishmaniasis: an update of current pharmacotherapy.
Sundar S; Chakravarty J
Expert Opin Pharmacother; 2013 Jan; 14(1):53-63. PubMed ID: 23256501
[TBL] [Abstract][Full Text] [Related]
36. The epidemiology and surveillance of visceral leishmaniasis in the Campania region of Italy. The value of zymodeme typing.
Gradoni L; Pizzuti R; di Martino L; Gramiccia M; Pempinello R; Gaeta GB; Ferrara M; Scotti S; Altieri S
Epidemiol Infect; 1993 Oct; 111(2):297-306. PubMed ID: 8405156
[TBL] [Abstract][Full Text] [Related]
37. Childhood visceral leishmaniasis in Muzaffarabad, Azad Jammu and Kashmir: frequency and response to treatment in 61 cases.
Altaf C; Ahmed P; Ashraf T; Anwar M; Ahmed I
J Pak Med Assoc; 2005 Nov; 55(11):475-8. PubMed ID: 16304865
[TBL] [Abstract][Full Text] [Related]
38. [Three Pediatric Cases of Leishmaniasis with Different Clinical Forms and Treatment Regimens].
Aydın Teke T; Metin Timur Ö; Gayretli Aydın ZG; Öz N; Bayhan Gİ; Yılmaz N; Mungan M; Tanır G
Turkiye Parazitol Derg; 2015 Jun; 39(2):147-50. PubMed ID: 26081889
[TBL] [Abstract][Full Text] [Related]
39. [Visceral leishmaniasis: retrospective study on factors associated with lethality].
Alvarenga DG; Escalda PM; Costa AS; Monreal MT
Rev Soc Bras Med Trop; 2010; 43(2):194-7. PubMed ID: 20464152
[TBL] [Abstract][Full Text] [Related]
40. [Infantile visceral leishmaniasis in the Campania region, Italy: experience from a Paediatric Referral Centre].
di Martino L; Gramiccia M; Occorsio P; Di Muccio T; Scalone A; Gradoni L
Parassitologia; 2004 Jun; 46(1-2):221-3. PubMed ID: 15305721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
